Clinical Trial Update: The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

View source ↗

Summary

Clinical trial NCT05712603, The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study, has completed according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Non-Alcoholic Fatty Liver Disease | Status: COMPLETED